Methyl Salicylate → HCID 21190859, compound

HRID 1068855Notes

Reaction equation

HRID 1068855 reaction equation
CC(C)([O-])C.[K+].[C:7]([O:16][CH3:17])(=[O:15])[C:8]1[C:9](=[CH:11][CH:12]=[CH:13][CH:14]=1)[OH:10].Br[CH2:19][C:20]1[CH:29]=[CH:28][C:27]2[C:22](=[CH:23][CH:24]=[CH:25][CH:26]=2)[CH:21]=1>CN(C)C=O>[CH:21]1[C:22]2[C:27](=[CH:26][CH:25]=[CH:24][CH:23]=2)[CH:28]=[CH:29][C:20]=1[CH2:19][O:10][C:9]1[CH:11]=[CH:12][CH:13]=[CH:14][C:8]=1[C:7]([O:16][CH3:17])=[O:15]

Participants

5

Reactant 3

HCID 4133Methyl SalicylateHCID 703202-BromomethylnaphthaleneHCID 23665647Potassium tert-butoxide

Product 1

HCID 21190859HCID 21190859, compoundYield 95%

Reagents, catalysts & solvents 1

HCID 6228DimethylformamideSolvent

Conditions

Temperature
100 °C

Procedure

3.9 g (35 mmol) of potassium tert-butoxide were added a little at a time to 5 g (33 mmol) of methyl salicylate in 200 ml of dimethylformamide). After about 15 min, 7.3 g (33 mmol) of 2-(bromomethyl)naphthalene were added and the reaction mixture was heated to 100° C. for about 3 h. The reaction mixture was then poured into ice-water and the product was extracted with ethyl acetate. The organic phase was dried and concentrated under reduced pressure. 9.15 g (95%) of the product were obtained.

Workup

  1. extractionthe product was extracted with ethyl acetate
  2. customThe organic phase was dried
  3. concentrationconcentrated under reduced pressure

Sources & evidence

ORD record
ord-837a459215a049958a384515eb0aec09
Source dataset
uspto-grants-2001_06
Patent number
US06251917B1

Reaction notes

Loading…